Skip to content

Investigation of the effects of 4-week ingestion of the development code GIC food

Investigation of the effects of 4-week ingestion of the development code GIC food - Investigation of the effects of 4-week ingestion of the development code GIC food

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000039217
Enrollment
24
Registered
2020-02-07
Start date
2020-01-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

In healthy males aged 20 to 59 years with a little lower lipid and glucose metabolism, daily ingestion of three GIC (development code) food capsules in a day (two capsules after lunch, one capsule aft

Sponsors

Kao Corporation
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: -Healthy males 1.Subjects with a little higher BMI. 2.Subjects with a little higher fasting blood glucose. 3.Subjects who have a drinking habit. 4.Subjects who have a smoking habit. 5.Subjects with chronic insufficient sleep.

Exclusion criteria

Exclusion criteria: -Subjects taking GIC (development code) analog on a daily basis. -Subjects with allergy or hypersensitivity to GIC (development code). -Subjects with systemic illness. -Subjects with a anamnesis of seizures based on nervous system disorders. -Subjects who regularly take medicine. -Subjects who has changed body weight more than +/- 3kg during 3 months before the test. -Subjects with skin diseases on their face. -Subjects undergoing beauty treatment (chemical peeling, laser treatment, etc.). -Subjects who do not agree not to change their usual cosmetics during the test period.

Design outcomes

Primary

MeasureTime frame
Evaluation of the effects of 4-week intake of GIC (development code) food on lipid and glucose metabolism, skin condition, body temperature, and so on.

Countries

Japan

Contacts

Public ContactMasafumi Aoki

Kao Corporation Biological Science Research

aoki.masafumi@kao.com+81-285-68-7522

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026